Skip to main content
. 2020 May 18;9(5):1515. doi: 10.3390/jcm9051515

Figure 3.

Figure 3

Forest plot representing the estimated pooled sensitivity of studies on Point-of-Care rapid tests for COVID-19. Mean specificity is 64.8% (95%CI 54.5–74.0). Notes on manufacturers of assessed kits: (1) Artron laboratories; (2) Acro Biotech; (3) AutoBio Diagnostics; (4) Dynamiker; (5) CTK Biotech; (6) VivaDiag; (7) AllTest Biotech; (8) Premier biotech; (9) Zhuhai Livzon Diagnostics; (0) undisclosed manufacturer.